Biogen Downgraded To Neutral From Overweight At Piper Jaffray
June 28, 2019 at 08:29 AM EDT
Piper Jaffray analyst Christopher Raymond downgraded Biogen to Neutral from Overweight and lowered his price target for the shares to $250 from $280.
